Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 154,831 |
|
|||||
| News | - | ||||||
| Day High | 23.64 | Low High |
|||||
| Day Low | 23.09 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Rocket Pharmaceuticals Inc | RCKT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.245 | -1.04% | 23.235 | 13:03:48 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 23.29 | 23.09 | 23.64 | 23.48 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,268 | 154,831 | $ 23.30 | $ 3,607,333 | - | 14.89 - 32.525 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:04:22 | 6 | $ 23.2478 | USD |
Rocket Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 8.15M | 90.50M | - | 0 | -245.6M | -2.71 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Rocket Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RCKT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 25.15 | 25.5513 | 23.09 | 23.96 | 668,218 | -1.92 | -7.61% |
| 1 Month | 27.95 | 27.98 | 23.09 | 25.19 | 599,334 | -4.72 | -16.87% |
| 3 Months | 28.72 | 31.47 | 23.09 | 27.64 | 717,078 | -5.49 | -19.10% |
| 6 Months | 16.80 | 32.525 | 16.55 | 25.81 | 803,812 | 6.44 | 38.30% |
| 1 Year | 18.80 | 32.525 | 14.89 | 22.83 | 868,296 | 4.44 | 23.59% |
| 3 Years | 43.25 | 49.66 | 7.565 | 21.35 | 739,560 | -20.02 | -46.28% |
| 5 Years | 17.27 | 67.48 | 7.565 | 23.40 | 594,062 | 5.97 | 34.54% |
Rocket Pharmaceuticals Description
| Rocket Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. |
